Energy intake and weight during the <scp>COVID</scp>‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in <scp>England</scp>

Arsenyadis, Franciskos; Redman, Emma; Henson, Joseph; Brady, Emer M; Coull, Nicole A.; Khunti, Kamlesh; Hall, Andrew P.; Davies, Melanie J.

doi:10.1111/dom.14585

Cited by 3 publications

(1 citation statement)

References 17 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study of older adults with T2D in England (mean age 65 years old) reported that energy intake and weight were not altered during the COVID-19 lockdown. 9 Older adults may normally stay at home more, so lockdown-related limitations may not have changed their habits as much as those changed among younger T2D patients.…”

Section: Discussionmentioning

confidence: 99%

Impact of National Lockdown From COVID-19 Pandemic in Patients With Type 2 Diabetes: An Observational Study

Thongtang

Chanwimol

Preechasuk

et al. 2022

Asia Pac J Public Health

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impact of National Lockdown From COVID-19 Pandemic in Patients With Type 2 Diabetes: An Observational Study

Thongtang

Chanwimol

Preechasuk

et al. 2022

Asia Pac J Public Health

View full text Add to dashboard Cite

Energy intake and weight during the COVID‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England

Arsenyadis

Redman

Henson

et al. 2021

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report

Vozza

Porfido

Delvino

et al. 2023

EMIDDT

View full text Add to dashboard Cite

Background: The Italian population’s habits changed dramatically during the “COVID-19 lockdown” due to physical distancing and self-isolation. Moreover, medical consultations of patients with chronic diseases, such as type 2 diabetes (T2D), were suspended or postponed, unless urgent or semi-urgent, for several consecutive months. Thus, it is expected that the lockdown could have affected glucometabolic control in T2D. Purpose: The aim of the study was to assess changes in glucometabolic control in a cohort of T2D patients before (T1) and after (T2) the COVID-19 lockdown (March-May 2020). Methods: The study was approved by the Ethics Committee of the University of Bari, and all patients provided informed written consent to participate. Medical history, complete physical examination, and laboratory assessment were conducted as real-life clinical practice. Changes in clinical and laboratory variables between T1 and T2 were calculated. Results: In detail, 13 patients were on metformin as monotherapy, 36 on GLP-1RA, 12 on sodium-glucose transporter 2 inhibitors (SGLT-2i), and 2 on dipeptidyl-peptidase 4 inhibitors (DPP4i). The mean age was 65.3 years (43-83). Study participants were mainly men (73%). The body weight (BW) ranged from 56 to 145 kg, and the waist circumference ranged from 88 to 146 cm. The mean HbA1c was 51.0 mmol/mol. At T2, no statistically significant changes were observed from baseline except for BW [-1.6 (-2.60 to -0.62)] and HbA1c [-2.90 (-4.69; -1.12)]. Conclusion: We evaluated the effects of the COVID-19 lockdown on glucometabolic control in patients with background well-controlled T2D. We found that the lockdown had no adverse effects on metabolic profile regardless of background clinical characteristics and antihyperglycemic management. Despite limitations due to the nature of this study (sample size, retrospective observation, lack of data on lifestyle changes in our patients' everyday lives), T2D patients managed in our Diabetes Centers faced the lockdown-related restrictions without any detrimental consequence.

show abstract

Energy intake and weight during the COVID‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England

Cited by 3 publications

References 17 publications

Impact of National Lockdown From COVID-19 Pandemic in Patients With Type 2 Diabetes: An Observational Study

Impact of National Lockdown From COVID-19 Pandemic in Patients With Type 2 Diabetes: An Observational Study

Energy intake and weight during the COVID‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England

The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report

Contact Info

Product

Resources

About